SCHEMBL6965573

SCHEMBL6965573

O=c1oc(-c2ccc(OCc3ccccn3)cc2)cc(O)c1SCCc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 0.40
PARP10 Q53GL7 1/20 0.40
MAPT P10636 1/20 0.40
ALDH1A1 P00352 2/20 0.39
BCHE P06276 2/20 0.39
ACHE P22303 2/20 0.39
KDM4E B2RXH2 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALOX5 P09917 1/20 0.39
ALOX5AP P20292 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
P2RY12 Q9H244 1/20 0.38
PTPN1 P18031 2/20 0.38
HTR1A P08908 1/20 0.38
DRD2 P14416 1/20 0.38
FFAR1 O14842 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CYSLTR1 Q9Y271 1/20 0.38
TERT O14746 1/20 0.38
FAAH O00519 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6952547 0.89 ABCB1 (0.50) ABCB1MAPTBCHEACHEL3MBTL1
SCHEMBL6963360 0.87 CYP19A1 (0.46) ABCB1MAPTACHESMN1; SMN2L3MBTL1
SCHEMBL6963290 0.86 TERT (0.43) ABCB1MAPTALDH1A1KDM4EL3MBTL1
SCHEMBL6959331 0.86 SYK (0.40) ABCB1HTR1ADRD2
SCHEMBL6956331 0.85 SLC16A3 (0.46) ABCB1MAPTBCHEACHEL3MBTL1
SCHEMBL6958378 0.84 MAOA (0.45) ABCB1BCHEACHEFFAR1
SCHEMBL6960907 0.84 ACHE (0.42) ABCB1MAPTALDH1A1BCHEACHE
SCHEMBL6953671 0.84 MRGPRX4 (0.48) SMN1; SMN2
SCHEMBL6954678 0.83 ABCB1 (0.43) ABCB1MAPTL3MBTL1FFAR1TERT
SCHEMBL6963656 0.83 CYP1A1 (0.44) ABCB1PARP10MAPTBCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US claimed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP claimed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO claimed
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed